Job OverviewThe Deputy Chief Manager of Learning and Development L D at Piramal Pharma will play a key role in enhancing the organization s learning ecosystem The role holder will be responsible for running 1 2 Functional Academies building and revamping the digital learning architecture and driving Leadership Academy initiatives This includes transitioning to a new Learning Experience Platform LXP to replace the existing Learning Management System LMS augmenting digital learning resources by introducing more content providers and managing leadership development programs The role will also involve learning analytics in partnership with the HR Analytics team to develop an L D dashboard and drive mandatory compliance modules The individual will foster and sustain a culture of continuous learning by leveraging both digital and traditional platforms KEY STAKEHOLDERS INTERNALHR Leadership Team Business HR Heads HR Business Partners COE Heads Business Learning Leaders Department Heads of various Corporate Functions Learners and Top Talent Groups KEY STAKEHOLDERS EXTERNALConsulting firms of repute training providers executive education and continuing education providers learning technology vendors learning content providers external professional bodies REPORTING STRUCTURE Deputy Chief Manager Learning Development will report to the General Manager Head of Learning and Development CoE Experience 4 to 8 years experience in Learning Development Leadership Development TM OD CompetenciesLearning Development Expertise Instructional design Facilitation Skills Digital Learning Solutions Experience with Learning Experience Platforms LXP e learning systems and managing digital content providers Leadership Development Proven track record in running leadership programs including designing and executing Building Continuous Learning Culture Passion for driving learning and development across an organization and engaging employees through cutting-edge learning experiences Learning Analytics Project Management Stakeholder Management Communication Influence In the three decades of its existence Piramal Group has pursued a twin strategy of both organic and inorganic growth Driven by its core values Piramal Group steadfastly pursues inclusive growth while adhering to ethical and values-driven practices Equal employment opportunityPiramal Group is proud to be an Equal Employment Opportunity and Affirmative Action employer We do not discriminate based upon race ethnicity religion color national origin gender including pregnancy childbirth or related medical conditions sexual orientation gender identity gender expression age status as a protected veteran status as an individual with a disability genetics or other applicable legally protected characteristics We base our employment decisions on merit considering qualifications skills performance and achievements We endeavor to ensure that all applicants and employees receive equal opportunity in personnel matters including recruitment selection training placement promotion demotion compensation and benefits transfers terminations and working conditions including reasonable accommodation for qualified individuals with disabilities as well as individuals with needs related to their religious observance or practice Piramal Pharma Limited PPL offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries PPL includes Piramal Pharma Solutions PPS an integrated Contract Development and Manufacturing Organization Piramal Critical Care PCC a Complex Hospital Generics business and the India Consumer Healthcare business selling over-the-counter products PPS offers end-to-end development and manufacturing solutions through a globally integrated network of facilities across the drug life cycle to innovators and generic companies PCC s complex hospital product portfolio includes inhalation anaesthetics intrathecal therapies for spasticity and pain management injectable pain and anaesthetics injectable anti-infectives and other therapies The Indian Consumer Healthcare business is among the leading players in India in the self-care space with established brands in the Indian consumer healthcare market In addition PPL has a joint venture with Allergan a leader in ophthalmology in the Indian formulations market In October 2020 the company received a growth equity investment from the Carlyle Group